Trials / Completed
CompletedNCT02386072
A Prospective, Observational, Multicenter Study of Patients Following Initiation of a New Course of Treatment for Overactive Bladder (OAB)
A Prospective, Non-interventional, Registry Study of Patients Initiating a Course of DrugTherapy for Overactive Bladder (OAB)
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,524 (actual)
- Sponsor
- Astellas Scientific & Medical Affairs, Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
A study to identify factors that are associated with improved effectiveness in pharmacologic therapy of Overactive Bladder, from the patient perspective primarily measured by OAB-Q-SF (Overactive Bladder Questionnaire Short Form)
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | mirabegron | oral |
| DRUG | antimuscarinic medication | oral |
Timeline
- Start date
- 2015-01-05
- Primary completion
- 2017-08-04
- Completion
- 2017-08-04
- First posted
- 2015-03-11
- Last updated
- 2024-10-16
Locations
92 sites across 2 countries: United States, Canada
Source: ClinicalTrials.gov record NCT02386072. Inclusion in this directory is not an endorsement.